Cargando…
FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway
BACKGROUND: Breast cancer (BC) is one of the commonest female cancers, which is characterized with high incidence. Although treatments have been improved, the prognosis of BC patients in advanced stages remains unsatisfactory. Thus, exploration of the molecular mechanisms underneath BC progression i...
Autores principales: | Tuluhong, Dilihumaer, Chen, Tao, Wang, Jingjie, Zeng, Huijuan, Li, Hanjun, Dunzhu, Wangmu, Li, Qiurong, Wang, Shaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033683/ https://www.ncbi.nlm.nih.gov/pubmed/33832493 http://dx.doi.org/10.1186/s12935-021-01866-3 |
Ejemplares similares
-
Downregulation of long non‐coding RNA Opa interacting protein 5‐antisense RNA 1 inhibits breast cancer progression by targeting sex‐determining region Y‐box 2 by microRNA‐129‐5p upregulation
por: Zeng, Huijuan, et al.
Publicado: (2018) -
FZD5 prevents epithelial-mesenchymal transition in gastric cancer
por: Dong, Dan, et al.
Publicado: (2021) -
TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer
por: Wang, Li, et al.
Publicado: (2019) -
HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018) -
C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
por: Ji, Huanhuan, et al.
Publicado: (2020)